C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 7/01 (2006.01) A61K 39/12 (2006.01) A61K 39/245 (2006.01) A61K 39/295 (2006.01) C12N 7/04 (2006.01) C12N 15/86 (2006.01)
Patent
CA 2101639
Novel Herpes simplex viruses and vaccines based on such novel HSV-1 strains are described. In particular, viruses having a deletion in the terminal portion of R L are provided. The virus can be further modified to express heterologous antigens and also engineered to overproduce HSV Light particles. This is achieved by incorporating a is mutation into the UL26 gene.
Brown Susanne M.
Maclean Alasdair R.
Borden Ladner Gervais Llp
Smithkline Beecham Biologicals S.a.
The University Court Of The University Of Glasgow
LandOfFree
Herpes simplex virus-1 deletion variants and vaccines thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Herpes simplex virus-1 deletion variants and vaccines thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Herpes simplex virus-1 deletion variants and vaccines thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1350213